The Greater Boston lab sector showed early signs of stabilization in the second quarter of 2026, recording its first period of positive net absorption in nearly a year. According to CBRE, the market managed to post a modest gain in occupied space even as broader fundamentals continued to reflect considerable slack and ongoing headwinds for landlords.
Total lab availability across the Greater Boston market in Q2 reached 32.8%, edging up 10 basis points from the first quarter and 60 basis points compared with the same quarter in 2025. Vacancy climbed more sharply on a year-over-year basis, up 250 basis points to 28.7%, underscoring that a large share of space is still sitting empty despite the quarter’s incremental leasing progress.
Net absorption for the quarter registered a positive 4,141 square feet. While small in absolute terms, this represents a reversal from the 117,186 square feet of negative absorption recorded in the first quarter, when tenants were giving back more space than they were taking. On a year-to-date basis, however, absorption remains in negative territory at 113,049 square feet, indicating that the market has yet to fully offset earlier contraction.
CBRE characterized the quarter’s results as “a tentative sign of stabilization amid persistent headwinds” and emphasized that overall conditions remain favorable for tenants. The improvement was not uniform across the region. Cambridge was the primary driver of the quarterly turnaround, posting nearly 194,000 square feet of positive net absorption. By contrast, suburban submarkets continued to contract, eroding some of the gains achieved in Cambridge and highlighting the uneven nature of the recovery across locations.
Pricing metrics continued to move in tenants’ favor. Rents declined for the fourth consecutive quarter, extending a trend that reflects both heightened competition among landlords and the depth of supply available to prospective occupiers. CBRE also noted that vacancy rose further from the prior period, even in the face of the quarter’s modest positive absorption, pointing to a market where new or existing space continues to outpace active demand.
CBRE’s assessment highlighted the fragility of any nascent recovery, citing the combination of elevated vacancy, rising availability and ongoing rent softening as evidence of a continued imbalance between supply and demand. While Cambridge’s performance offers an early sign that leasing momentum can return in core locations, the weaker results in suburban lab submarkets suggest that the broader Greater Boston life science market may require additional time for fundamentals to realign. For now, tenants retain meaningful leverage on space selection, pricing and lease terms, with landlords facing continued pressure to differentiate both product and deal structures in order to attract and retain occupants.
